New Jersey, USA-based cancer giant Merck & Co (NYSE: MRK) has announced it will unveil a comprehensive slate of new research ...

USA-based Inozyme Pharma, a biopharma developing innovative therapeutics for rare diseases that affect bone health and blood ...

Swiss pharma giant Novartis will spotlight key data across its oncology portfolio, including Kisqali (ribociclib), Scemblix ...

US pharma giant Merck & Co (NYSE: MRK) today announced that the Phase III KEYNOTE-B96 trial, also known as ENGOT-ov65, met ...

The integration of genomics into the pharmaceutical industry has allowed researchers to better understand the genetic factors ...

Emrelis (telisotuzumab vedotin-tllv) has been granted accelerated approval by the US Food and Drug Administration (FDA), said ...

In a world where western firms increasingly seek to ingratiate themselves with Middle Eastern leaders and investors, a Saudi ...

Swedish biotech firm PeptiSystems has joined forces with Asahi Kasei Bioprocess America in a global partnership set to ...

London-based specialty pharmaceutical company CNX Therapeutics is set to fast-track its European growth strategy after being ...

German science and technology company Merck (MRK: DE) reported a solid start to 2025, with group net sales rising 2.5% ...

German pharmaceutical company Boehringer Ingelheim has entered a multi-year collaboration with Tempus AI (Nasdaq: TEM), ...

Aiming to expand its hepatology portfolio, UK pharma major GSK (LSE: GSK) yesterday announced that it has entered into an ...